2015-05-04 - Unknown
900333152
| Adverse reaction report number | 900333152 |
| Latest AER version number | 0 |
| Market authorization holder AER number | CA201405131 |
| Initial received date | 2015-05-04 |
| Latest received date | 2015-05-04 |
| Age | N/A |
| Gender | Unknown |
| Weight | N/A |
| Type of report | Other |
| Reporter type | Consumer Or Other Non Health Professional |
| Source of report | MAH |
| Report outcome | Unknown |
| Serious report? | No |
| Product description | Dosage form | Health product role | Route of administration | Dose | Frequency | Therapy duration | Indication(s) |
|---|---|---|---|---|---|---|---|
| ADDERALL XR | Suspect | Oral | 1 every 1 Day(s) | Product used for unknown indication | |||
| ADDERALL XR | CAPSULE, EXTENDED RELEASE | Suspect | Oral | 2 every 1 Day(s) | Product used for unknown indication | ||
| VYVANSE | CAPSULE | Suspect | Oral | 1 every 1 Day(s) | Product used for unknown indication | ||
| VYVANSE | CAPSULE | Suspect | Oral | 2 every 1 Day(s) | Product used for unknown indication | ||
| VYVANSE | CAPSULE | Suspect | Oral | Product used for unknown indication |
| MedDRA version: v.21.1 | |
| Adverse reaction terms | Reaction duration |
|---|---|
| Inappropriate schedule of product administration | |
| Prescribed overdose | |
| Therapeutic response shortened | |